Market Cap 51.40M
Revenue (ttm) 83.81M
Net Income (ttm) -240.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -287.22%
Debt to Equity Ratio -3.01
Volume 598,400
Avg Vol 469,412
Day's Range N/A - N/A
Shares Out 9.79M
Stochastic %K 90%
Beta 0.41
Analysts Hold
Price Target $14.67

Latest News on BLUE

bluebird bio Announces 1-for-20 Reverse Stock Split

Dec 4, 2024, 4:05 PM EST - 4 months ago

bluebird bio Announces 1-for-20 Reverse Stock Split


bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:06 AM EST - 4 months ago

bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript


Bluebird Bio (BLUE) Stock Dips Amid Market Volatility

Oct 8, 2024, 3:53 PM EDT - 6 months ago

Bluebird Bio (BLUE) Stock Dips Amid Market Volatility


Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements

Oct 2, 2024, 4:11 PM EDT - 6 months ago

Bluebird Bio (BLUE) Stock Surges 5.04% Amid Market Movements


Bluebird bio to cut 25% of workforce as part of restructuring

Sep 24, 2024, 7:08 AM EDT - 6 months ago

Bluebird bio to cut 25% of workforce as part of restructuring


bluebird bio Announces September Investor Events

Aug 28, 2024, 8:00 AM EDT - 7 months ago

bluebird bio Announces September Investor Events


bluebird bio Announces Receipt of Expected Notices from Nasdaq

Aug 23, 2024, 4:05 PM EDT - 7 months ago

bluebird bio Announces Receipt of Expected Notices from Nasdaq


bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:14 AM EDT - 8 months ago

bluebird bio, Inc. (BLUE) Q2 2024 Earnings Call Transcript


bluebird bio Announces Second Quarter 2024 Results Call Date

Aug 12, 2024, 8:00 AM EDT - 8 months ago

bluebird bio Announces Second Quarter 2024 Results Call Date


Bluebird bio appoints new CFO to oversee financial restatements

May 29, 2024, 8:56 AM EDT - 11 months ago

Bluebird bio appoints new CFO to oversee financial restatements


bluebird bio Appoints O. James Sterling as Chief Financial Officer

May 29, 2024, 7:00 AM EDT - 11 months ago

bluebird bio Appoints O. James Sterling as Chief Financial Officer